95-18042. Workplace Drug and Alcohol Testing Programs  

  • [Federal Register Volume 60, Number 142 (Tuesday, July 25, 1995)]
    [Notices]
    [Pages 38204-38205]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-18042]
    
    
    
    
    Federal Register / Vol. 60, No. 142 / Tuesday, July 25, 1995 / 
    Notices 
    
    [[Page 38204]]
    
    
    DEPARTMENT OF TRANSPORTATION
    
    Office of the Secretary
    
    
    Workplace Drug and Alcohol Testing Programs
    
    AGENCY: Office of the Secretary, DOT.
    
    ACTION: Notice: Guidance on the Role of Consortia and Third-Party 
    Administrators in DOT Drug and Alcohol Testing Programs.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Department of Transportation encourages the provision of 
    drug and alcohol testing services through consortia and third-party 
    administrators. The guidance in this notice responds to a number of 
    questions that have arisen about the proper role of these organizations 
    in assisting employers to meet the requirements of the Department's 
    drug and alcohol testing regulations.
    
    FOR FURTHER INFORMATION CONTACT: Albert Alvarez, Director, Office of 
    Drug Enforcement and Program Compliance 400 7th Street SW., Room 9404A. 
    202-366-3784; or Robert C. Ashby, Deputy Assistant General Counsel for 
    Regulation and Enforcement, 400 7th Street SW., Room 10424. 202-366-
    9306.
    
    SUPPLEMENTARY INFORMATION: The Department of Transportation's drug and 
    alcohol testing programs require employers to take a variety of actions 
    to ensure a transportation workplace free of drug and alcohol misuse. 
    Consortia and third-party administrators (C/TPAs) can play an important 
    role in assisting employers to meet these requirements, and the 
    Department's policy is to encourage their availability to employers. At 
    the same time, the Department is committed to ensuring that the 
    confidentiality of the testing process for employees is not 
    compromised.
        The following guidance spells out the Department's views and 
    interpretations of the proper role of C/TPAs in DOT drug and alcohol 
    testing programs. It responds to a number of questions that 
    participants have raised about the place of these organizations. This 
    is Department-wide guidance, applying to participants in the programs 
    of all DOT operating administrations involved: the Federal Aviation 
    Administration (FAA), Federal Railroad Administration (FRA), Federal 
    Highway Administration (FHWA), Federal Transit Administration (FTA), 
    United States Coast Guard (USCG), and Research and Special Programs 
    Administration (RSPA).
    
    General Role and Functions of C/TPAs
    
         Employers are permitted to use C/TPAs to carry out certain 
    aspects of their drug and alcohol testing programs.
         If an employer uses a C/TPA to implement its program, the 
    employer must ensure that the C/TPA performs its services in accordance 
    with the applicable rules.
         C/TPAs may operate random testing programs for employers 
    and may facilitate the conduct of other functions (e.g., contracting 
    with labs or collectors, conducting collections).
         C/TPAs may combine employees from more than one entity or 
    one industry in a random pool. It should be noted that employees not 
    covered by DOT rules may not be part of the same random pool with DOT 
    employees, that adjustment to random testing rates in various 
    industries may complicate the ability of C/TPAs to operate multi-
    industry pools, and that any C/TPA including aviation employees must be 
    approved by the FAA.
         C/TPAs may assist medical review officers and substance 
    abuse professionals (MROs/SAPs) in ensuring that follow-up testing is 
    conducted in accordance with the schedule established by the MRO/SAP. 
    Like an employer, a C/TPA may not randomly select employees from a 
    ``follow-up pool'' for follow-up testing. (Follow-up testing, while 
    unannounced, is not random: it follows individualized directions 
    established by the MRO/SAP for the particular employee.)
         The C/TPA acts as an agent of the employer, and ``stands 
    in the shoes'' of the employer, subject to certain limits. Within these 
    limits, the duties the rule assigns to employers are to be carried out 
    by the C/TPAs acting as their agents. Because the C/TPA acts as an 
    agent of the employer, it is not required that the employee provide 
    written consent to permit the employer to provide confidential 
    information to the C/TPA (e.g., individual test results). In their role 
    as agents of the employer, C/TPAs must follow the same confidentiality 
    rules as the employer itself.
         Limits on use of C/TPAs as agents include the following:
        * A C/TPA cannot make reasonable suspicion, post-accident, or -
    refusal determinations. This is a non-delegable duty of the -employer 
    itself.
        * The employer itself is responsible for making sure that an 
    employee who has tested positive for alcohol or drugs, or otherwise 
    violated the rules, is removed from performance of safety-sensitive 
    positions.
        * As noted above, an employer cannot delegate responsibility for 
    compliance to C/TPA. The employer remains obligated to DOT for 
    compliance, and the C/TPA's failure to implement any aspect of the 
    program as required in Part 40 and applicable operating administration 
    regulations makes the employer subject to enforcement action by the 
    Department.
        * A C/TPA cannot act as ``program manager'' in FAA and RSPA 
    programs, which call for the employer itself to have an individual 
    designated to manage the drug and alcohol testing program for the 
    employer.
        * The fact that a C/TPA stands in the employer's shoes does not 
    obviate the C/TPA's obligation to transmit quarterly laboratory 
    statistical summaries to each actual employer.
        * The limitations on self-referrals by SAPs for treatment apply in 
    situations in which SAPs are part of a C/TPA.
        * It is not appropriate for laboratories to receive drug and 
    alcohol forms for an individual packaged or attached (e.g., stapled) 
    together, since this is inconsistent with the privacy and 
    confidentiality of personally-identified test records. Consequently, C/
    TPAs (including those that are operated by or affiliated with 
    laboratories) must ensure that laboratories receive only the drug chain 
    of custody form. One useful way in which C/TPAs can implement this 
    guidance is to establish separate addresses for the receipt of drug and 
    alcohol forms, respectively. C/TPAs could also establish procedures to 
    separate alcohol and drug forms that arrive together.
    
    Confidentiality, Test Results, Recordkeeping
    
         C/TPAs may receive from employers or other parties and 
    maintain all records concerning DOT alcohol and drug testing programs, 
    including individual test results, both positive and negative. Record 
    retention requirements (i.e., requirements that records be maintained 
    for a certain amount of time) apply to records maintained by C/TPAs in 
    the same way as the requirements apply to employers.
         Where operating administration rules or policies require 
    employers to keep certain information in their own files (e.g., for 
    purposes of review during inspections), employers must do so, even 
    though the same information is maintained by a C/TPA for other 
    purposes.
         Information needed for operating a drug/alcohol program 
    (e.g., names of employees in random pool, random selection lists, 
    copies of notices to employers of selected employees) may be maintained 
    by C/TPAs. Consortia may make random selections from the 
    
    [[Page 38205]]
    pool and notifications of random tests. If the C/TPA does not maintain 
    this information, the employer itself must do so.
         If the C/TPA is conducting or arranging for drug testing, 
    the employer's copy of the COC form may pass through the C/TPA to 
    provide notice to the C/TPA that the employee's specimen has been 
    collected. The document must be forwarded to the actual employer, if 
    required by applicable operating administration rules. -
         C/TPAs must follow all confidentiality requirements 
    applicable to employers.
        * Like an employer, a C/TPA may not provide individual test results 
    or other confidential information to another employer without a 
    specific, written consent from the employee. For example, suppose a 
    consortium has employers X and Y as members. Employee Jones works for 
    X, and has a drug or alcohol test result kept for X by the consortium. 
    Jones wants to change jobs and work for Y. The consortium may not 
    inform Y of the test result without obtaining specific, written consent 
    from Jones. Likewise, the consortium cannot provide this information to 
    Z, who is not a consortium member, without Employee Jones' consent.
        * Blanket consent forms authorizing the release of employee testing 
    information by C/TPAs to a third party are not permitted.
        * C/TPAs must establish adequate confidentiality and security 
    measures to ensure that confidential employee records are not available 
    to unauthorized persons. This includes protecting the physical security 
    of records, limiting the number of persons with access to the records 
    and other appropriate access controls, and computer security measures 
    to safeguard confidential data in electronic data bases.
    
    Medical Review Officer Issues
    
         Employers may obtain MRO services through C/TPAs. While 
    the conflict-of-interest provisions of Part 40 concerning relationships 
    between laboratories and MROs apply, they do not prevent independent C/
    TPAs (e.g., a C/TPA not operated by a laboratory) from employing or 
    contracting with MROs or contracting for laboratory services.
         If an MRO is employed or contracted for by a C/TPA, the 
    MRO must perform duties independently and confidentially. C/TPAs which 
    have relationships with MROs must structure these relationships to 
    ensure that this independence and confidentiality are not compromised. 
    Specific means (including both physical and operational provisions, as 
    appropriate) to separate MRO functions and other C/TPA functions are 
    essential. The purpose of this mechanism is to ensure that the MRO is 
    independently in charge of all MRO functions and that, with respect to 
    performing MRO-related functions, C/TPA staff are subject to the 
    direction and control only of the MRO.
         Only those C/TPA staff members who are actually under the 
    day-to-day supervision and control of an MRO with respect to MRO 
    functions may perform these functions. This does not mean that those 
    staff may not perform other functions at other times. However, the 
    designation of C/TPA staff as MRO purposes should be limited and not 
    used as a subterfuge to circumvent confidentiality requirements in DOT 
    rules and guidance. MRO staff must also operate under controls 
    sufficient to ensure that the independence and confidentiality of the 
    MRO process are not compromised (see previous paragraph).
         Confirmed test results must be sent directly from the 
    laboratory to the MRO or MRO staff designated in accordance with this 
    guidance. For example, a practice in which results are transmitted from 
    a laboratory to a C/TPA computer system, and then assigned to an 
    available MRO, is inconsistent with this guidance.
         MROs must personally conduct the final interviews with 
    employees who have tested positive and must personally make the 
    decision concerning whether to verify a test as positive or negative. 
    MRO staff cannot perform these functions.
         MROs and BATs must send final individual test results 
    directly to the actual employer as soon as the results are available, 
    since it is employers who have the authority to remove employees from 
    performing safety-sensitive functions. While results may be maintained 
    afterwards by the C/TPA, and while there is no objection to the MRO or 
    BAT transmitting results simultaneously both to the employer and to the 
    C/TPA, it is not appropriate for the MRO or BAT to send the results 
    only to the C/TPA, which subsequently retransmits them to the employer. 
    This is true even where the MRO or BAT is employed by or under contract 
    with the C/TPA. Operating administrations are authorized to make 
    exceptions to this general rule in situations where it may be 
    impracticable for the individual test results to be sent to individual 
    employers before going to the C/TPA (e.g., where a C/TPA is the only 
    party in a position to inform an owner-operator who has tested positive 
    that he or she must cease performing safety-sensitive functions).
    
    Enforcement
    
         Consistent with this guidance, employers may contract out 
    their drug and alcohol testing functions to C/TPAs; employers may not 
    contract away their responsibility to comply with DOT rules.
         DOT regulates employers, not C/TPAs (with the exception of 
    FAA's approval process for C/TPAs in the aviation industry). It is the 
    employer, not the C/TPA, who must answer to DOT for noncompliance with 
    DOT requirements if the employer's C/TPA does not properly carry out 
    the requirements of DOT rules.
    
        Issued this 11th day of July, 1995 at Washington D.C. -
    Federico Pena, -
    Secretary of Transportation.
    [FR Doc. 95-18042 Filed 7-24-95; 8:45 am]
    BILLING CODE 4910-62-U
    
    

Document Information

Published:
07/25/1995
Department:
Transportation Department
Entry Type:
Notice
Action:
Notice: Guidance on the Role of Consortia and Third-Party Administrators in DOT Drug and Alcohol Testing Programs.
Document Number:
95-18042
Pages:
38204-38205 (2 pages)
PDF File:
95-18042.pdf